MED BIOGENE
Med BioGene Inc. (MBI) is a life science company based in Vancouver, British Columbia, that is currently focused on managing the license and rights to GeneFx® Lung (formerly, LungExpress Dx), a proprietary gene expression-based test for early-stage non-small-cell lung cancer. GeneFx Lung is expected to provide better-informed and personalized treatment decisions to assist in the selection of patients for adjuvant chemotherapy. MBI has partnered with Precision Therapeutics for the global commercialization of GeneFx Lung. MBI's common shares are traded on the TSX Venture Exchange.
MED BIOGENE
Industry:
Biotechnology Genetics
Founded:
2006-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.medbiogene.com
Total Employee:
1+
Status:
Active
Contact:
1(604)732-4801
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail GoDaddy DNS Parallels Plesk Panel 1and1 HTTrack Website Copier Parallels SSL
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.medbiogene.com
- Host name: mtlr103.websitehostserver.net
- IP address: 70.38.9.116
- Location: Montreal Canada
- Latitude: 45.4579
- Longitude: -73.5493
- Timezone: America/Toronto
- Postal: H3E
